| Date Filed | Type | Description |
| 09/17/2018 |
15-12G/A
| Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] |
| 05/08/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
| 03/16/2018 |
RW
| Form RW - Registration Withdrawal Request: |
| 02/20/2018 |
10-Q
| Quarterly Report for the period ended December 31, 2017 |
| 02/14/2018 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 02/06/2018 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 01/25/2018 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 01/17/2018 |
SC 13G
| Oceanside Strategies, Inc. reports a 7.7% stake in EnzymeBioSystems |
| 01/11/2018 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 01/03/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/14/2017 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 11/09/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
| 10/24/2017 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/24/2017 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/13/2017 |
10-K
| Annual Report for the period ended June 30, 2017 |
| 10/02/2017 |
8-K
| Quarterly results |
| 09/28/2017 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 09/15/2017 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 05/19/2017 |
10-Q
| Quarterly Report for the period ended March 31, 2017 |
| 05/15/2017 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 02/27/2017 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 02/14/2017 |
10-Q
| Quarterly Report for the period ended December 31, 2016 |
| 01/17/2017 |
8-K
| Form 8-K - Current report |
| 11/22/2016 |
10-Q
| Quarterly Report for the period ended September 30, 2016 |
| 11/14/2016 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 09/20/2016 |
10-K
| Annual Report for the period ended June 30, 2016 |
| 05/02/2016 |
10-Q
| Quarterly Report for the period ended March 31, 2016 |
| 03/31/2016 |
10-Q
| Quarterly Report for the period ended December 31, 2015 |
| 02/16/2016 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 12/08/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
| 11/12/2015 |
10-K
| Annual Report for the period ended June 30, 2015 |
| 11/04/2015 |
SC 13D
| Quattro Associates reports a 21% stake in EnzymeBioSystems |
| 10/13/2015 |
8-K
| Changes in Registrant's Certifying Accountant, Other Events, Financial Statements and Exhibits |
| 09/25/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|